Literature DB >> 10545258

Virus-receptor interactions of human parainfluenza viruses types 1, 2 and 3.

C Ah-Tye1, S Schwartz, K Huberman, E Carlin, A Moscona.   

Abstract

Human parainfluenza viruses types 1, 2 and 3 (HPF 1, 2 and 3) are important pathogens in children. While these viruses share common structures and replication strategies, they target different parts of the respiratory tract; the most common outcomes of infection with HPF3 are bronchiolitis and pneumonia, while HPF 1 and 2 are associated with croup. While the HPF3 fusion protein (F) is critical for membrane fusion, our previous work revealed that the receptor binding hemagglutinin-neuraminidase (HN) is also essential to the fusion process; interaction between HN and its sialic acid-containing receptor on cell surfaces is required for HPF3 mediated cell fusion. Using our understanding of HPF3 HN's functions in the cell-binding and viral entry process, we are investigating the ways in which these processes differ in HPF 1 and 2, in part by manipulating receptor availability. Three experimental treatments were used to compare the HN-receptor interaction of HPF 1, 2 and 3: infection at high multiplicity of infection (m.o.i.); bacterial neuraminidase treatment of cells infected at low m.o.i.; and viral neuraminidase treatment of cells infected at low m.o.i. (using Newcastle disease virus [NDV] neuraminidase or UV irradiated HPF3 as sources of neuraminidase). In cells infected with HPF3, we have shown that infection with high m.o.i. blocks fusion, by removing sialic acid receptors for the viral HN. However, in cells infected with HPF 1 and 2, infection with high m.o.i. did not block fusion; the fusion increases with increasing m.o.i. In cells infected with HPF 1 and 2, neither bacterial nor NDV neuraminidase blocked cell fusion, using amounts of neuraminidase that completely block fusion of HPF3 infected cells. However, when inactivated HPF3 was used as a source of viral neuraminidase, the treatment inhibited fusion of cells infected with HPF 1 and 2 as well as 3. The differences found between these viruses in terms of their interaction with the cell, ability to modulate cell-cell fusion and response to exogenous neuraminidases of various specificities, may reflect salient differences in biological properties of the three viruses. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10545258     DOI: 10.1006/mpat.1999.0313

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  16 in total

1.  A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo.

Authors:  Anne Moscona; Matteo Porotto; Samantha Palmer; Caroline Tai; Lori Aschenbrenner; Gallen Triana-Baltzer; Qi-Xiang Li; David Wurtman; Stefan Niewiesk; Fang Fang
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

2.  Mechanism of interference mediated by human parainfluenza virus type 3 infection.

Authors:  M A Horga; G L Gusella; O Greengard; N Poltoratskaia; M Porotto; A Moscona
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Sialidase-based anti-influenza virus therapy protects against secondary pneumococcal infection.

Authors:  Maria Hedlund; Laura M Aschenbrenner; Kellie Jensen; Jeffrey L Larson; Fang Fang
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

4.  Effects of hemagglutinin-neuraminidase protein mutations on cell-cell fusion mediated by human parainfluenza type 2 virus.

Authors:  Masato Tsurudome; Machiko Nishio; Morihiro Ito; Shunsuke Tanahashi; Mitsuo Kawano; Hiroshi Komada; Yasuhiko Ito
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

5.  Receptor specificities of human respiroviruses.

Authors:  T Suzuki; A Portner; R A Scroggs; M Uchikawa; N Koyama; K Matsuo; Y Suzuki; T Takimoto
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Fixation of oligosaccharides to a surface may increase the susceptibility to human parainfluenza virus 1, 2, or 3 hemagglutinin-neuraminidase.

Authors:  Mary M Tappert; David F Smith; Gillian M Air
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

7.  Inhibition of primary clinical isolates of human parainfluenza virus by DAS181 in cell culture and in a cotton rat model.

Authors:  B G Jones; R T Hayden; J L Hurwitz
Journal:  Antiviral Res       Date:  2013-09-27       Impact factor: 5.970

8.  Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells.

Authors:  Santanu Bose; Mausumi Basu; Amiya K Banerjee
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity.

Authors:  Laura M Palermo; Matteo Porotto; Christine C Yokoyama; Samantha G Palmer; Bruce A Mungall; Olga Greengard; Stefan Niewiesk; Anne Moscona
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

Review 10.  Parainfluenza viruses.

Authors:  Kelly J Henrickson
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.